Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€205.90

€205.90

-0.150%
-0.3
-0.150%
€212.17

€212.17

 
10.08.26 / Tradegate WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Stock / Healthcare Providers & Services / Large Cap /
Latest predictions
€228.49
24.07.26
2.69%
buy
23.07.26
2.86%
buy
23.07.26
2.85%
buy
€195.85
22.04.26
18.20%
buy
21.04.26
17.66%
buy
10.02.26
19.33%
buy
Best running prediction
-
21.10.25
29.37%
buy
Your prediction

Quest Diagnostics Inc. Stock

The price for the Quest Diagnostics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.300 (-0.150%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Quest Diagnostics Inc..
With a target price of 212 € there is a slightly positive potential of 2.96% for Quest Diagnostics Inc. compared to the current price of 205.9 €.

Pros and Cons of Quest Diagnostics Inc. in the next few years

Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Quest Diagnostics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Quest Diagnostics Inc. -0.150% 2.184% 13.287% 37.680% 38.049% 68.563% 62.382%
Universal Health Services B 0.000% 2.041% 9.489% 2.740% -21.875% 25.000% 19.474%
HCA Holdings Inc. -0.170% 1.557% 0.702% 11.989% -10.948% 46.888% 74.635%
Anthem Inc. 1.000% 3.578% -5.539% 36.382% 17.018% -19.131% 7.021%

Comments

Prediction Buy
Perf. (%) 2.69%
Target price 228.488
Change
Ends at 24.07.27

Quest Diagnostics (DGX) had its price target raised by Mizuho from $235.00 to $260.00. They now have an "outperform" rating on the stock.
Ratings data for DGX provided by MarketBeat
Show more

Thanks for sharing such an informative post 👍https://fawanewssc.com/
Show more

Quest Diagnostics (DGX) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for DGX provided by MarketBeat
Show more